Searched for
MANUFACTURING ROLES IN CDMO
AI-linked hiring in CDMO industry jumps nearly 3-fold in 2 years: ReportArtificial intelligence skill demand in India's Contract Development and Manufacturing Organisation sector is set to surge. Demand for AI s...- ETMarkets PMS Talk | A 'private equity approach' to public markets has driven our investing success for 15 years: Sameer ShahValueQuest's Sameer Shah champions a private equity approach to public markets. He focuses on deep research and conviction in identifying t...
- True North buys 25% stake in pharma co EmbioPrivate equity firm True North is investing approximately $50 million in Embio Ltd. Embio manufactures Active Pharmaceutical Ingredients fo...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Abhay Agarwal bets on midcaps, import substitution themes for growthDespite persistent global uncertainties and foreign outflows, Indian market sentiment is driven by liquidity constraints rather than stretc...
- From Pilot to Plant Floor: Industrial AI Moves from Boardroom to Assembly LineIndia's factories are now using industrial AI for real-time operations. This shift from planning to doing is improving quality and efficien...
- Mutual funds bet big on healthcare, outpace BSE 200 exposure. Should you join in?Mutual funds significantly increased their allocation to the healthcare sector in February 2026, making it their fourth-largest exposure. T...
- India’s generic pharma faces tariff uncertainty but retains edge in US market: JPMorgan analystIndia’s generic pharma faces tariff uncertainty but retains edge in US market: JPMorgan analyst
- Pharmexcil drives global pharma trade through premier healthcare export summitThe 11th edition of iPHEX, India's flagship pharmaceutical export exhibition, will be held in New Delhi from September 4-6, 2025.
- Piramal Healthcare targets $2 bn revenue by FY30, to focus on organic expansion: Chairperson Nandini PiramalPiramal Healthcare prioritizes organic growth for the next 4-5 years. The company will explore licensing and product acquisitions in comple...
- Use market dips to build portfolios; these 8 sectors have high growth potential: Alok AgarwalAlok Agarwal from Alchemy Capital highlights India's growth potential. He advises against market timing, suggesting dips are buying opportu...
- China’s India headache: The growing pharmaceutical industryIndian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring trend and a desir...
- Growth at reasonable price our core focus; underweight banks and IT: Sumit Jain, ASK Investment ManagersASK Investment Managers is navigating market volatility with a focus on quality and growth stocks, favoring manufacturing, consumption, and...
- US tariffs will have minimal impact on Indian pharma service companies like CDMOs: ReportExporters can pass on cost increases to consumers, and the favourable USD/INR exchange rate and increased outsourcing opportunities are exp...
- Planning to spot wealth creators in chemical space? PI Industries, Atul could give over 20% return eachIndia is positioning its chemical and petrochemical industry to become a global leader. The sector aims to increase its output to USD6 tril...
- India could account for 8-10 pc of work share outsourced to CDMOs by 2033: ReportIndia could take 8-10% of the global outsourcing share for Contract Research Development and Manufacturing Organisations by 2033 due to wor...
- Piramal Pharma stock in focus on $80 million expansion plan for Kentucky injectables facilityPiramal Pharma Solutions, is investing $80 million to expand its Lexington facility, doubling capacity by Q1 2027 to meet growing injectabl...
- PE Advent completes acquisition of Suven Pharma, appoints new Board and management teamPrivate equity firm Advent International has completed its majority acquisition of Indian contract development and manufacturing organisati...
- Encube Ethicals gets funding from Quadria Capital, others at $800 million valuationEncube Ethicals’ funding round, that saw participation of Quadria Capital and Gulf Islamic Investments, provides an exit to early backer Re...
Load More
